Search

News
Publications
Team
Contact

Heidi Fassnacht-Riederle

Latest

Clinical outcome after switching therapy from ranibizumab and/or bevacizumab to aflibercept in central retinal vein occlusion

© {2022} Maximilian Pfau

Published with Wowchemy — the free, open source website builder that empowers creators.

Cite